logo
episode-header-image
Sep 2024
17 m

Doxorubicin + Trabectedin

JOHN BOSSAER
About this episode
LMS04 final OS results are published for doxorubicin + trabectedin in Leiomyosarcoma. Plus, a natural experiment of what happens in small cell lung cancer during an IV etoposide shortage. Finally, a nice paper provides some examples of how oncology pharmacists can bridge the care gap between oncology and primary care. LMS04: https://www.nejm.org/doi/pdf/1 ... Show More
Up next
Aug 21
Venetoclax Dosing & APOLLO
Malignant Hematology Updates: Venetoclax dosing strategies continue to evolve HMA/Ven + IDH1/2 inhibitors: https://doi.org/10.1200/JCO-25-00640 HMA/Ven + revumenib: https://doi.org/10.1200/JCO-25-00914 Venetoclax + CPX-351: https://doi.org/10.1002/ajh.27723 APOLLO: https://doi.or ... Show More
17m 47s
Aug 14
Zongertinib
A new ERBB2 (HER2) targeting TKI is approved for NSCLC. We review the characteristics of the drug and summarize the current landscape in treating HER-mutated advanced NSCLC. 
12m 7s
Aug 7
Dordaviprone & RCT to prevent ADRs
This week's episode discusses the first-in-class agent, dordaviprone and a randomized control trial that demonstrated an oncology pharmacists led to decreased rates of adverse drug reactions (ADRs) in a Hem/Onc clinic. Dordaviprone data: https://doi.org/10.1200/jco.23.01134 Alaba ... Show More
11m 30s
Recommended Episodes
Dec 2024
2024 State of Lung Cancer: The Hopes and Hurdles of Precision Oncology with Dr. Jacob Sands
For a probing discussion detailing the American Lung Association’s recent 2024 “State of Lung Cancer” report, we are joined by esteemed thoracic medical oncologist Dr. Jacob Sands of Dana-Farber Cancer Institute and Harvard Medical School. Offering insight into actionable targete ... Show More
33m 9s
Jul 2024
S2 Episode 4: The Evolution of Nonoperative Rectal Cancer Management
Join Drs Benjamin Schlechter and Joshua Smith as they discuss the evolution of nonoperative rectal cancer management and organ preservation, highlighting groundbreaking trials like OPRA and JANUS. Relevant disclosures can be found with the episode show notes on Medscape https://w ... Show More
26m 27s
Jun 2021
Review Series on Platelets and Cancer
Platelets are critical for hemostasis and thrombosis, but recent research highlights their role in many other processes, including inflammation, wound healing, and lymphangiogenesis. In this episode, Drs. José López, Elisabeth Battinelli, Craig Williams, and Owen McCarty discuss ... Show More
35m 27s
Oct 2019
OVFTP Cancer Treatment: FIGO’s 2018 Summary
In our previous episode, we covered the revised FIGO ovarian cancer staging which now includes fallopian tube and peritoneal malignancies. In this episode, we will cover the FIGO guidelines regarding the management of OVFTP cancer. What role do PARP inhibitors play? Does treatmen ... Show More
12m 22s
Mar 2024
Biotech for our Pets
More than half of U.S. households include pets, but there has been a lack of medical treatments developed specifically for small animals. Biotech companies are working to change that with new treatment options that both borrow from and, potentially, advance human health discoveri ... Show More
28m 21s
Sep 2022
Oncology | Acute Lymphoblastic Leukemia (ALL)
In this episode, we review the high-yield topic of Acute Lymphoblastic Leukemia (ALL) from the Oncology section. Follow Medbullets on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets 
11m 13s
Nov 2024
Ep 123: 65-Year-Old Male with Hepatocellular Carcinoma (HCC)
This episode presents a 65-year-old man recently who was diagnosed with hepatocellular carcinoma. We discuss environmental risk factors for the development of malignancy. 
7m 15s
Jun 2023
Unleashing CRISPR on Cancer
In this episode of “Intention to Treat,” host Rachel Gotbaum explores the story of a teenager who’s now in remission from previously relapsed lymphoblastic leukemia and talks with the investigator who developed the “off-the-shelf” CAR T cells that made her treatment possible. A f ... Show More
52m 50s
Aug 14
11: Navigating the Evolving Second-Line Landscape of Metastatic Urothelial Carcinoma
The latest Oncology Decoded discussion with Manojkumar Bupathi, MD, MS, executive cochair of the Genitourinary Cancer Research Executive Committee at Sarah Cannon Research Institute (SCRI) and medical oncologist with Rocky Mountain Cancer Centers specializing in solid tumors and ... Show More
41m 45s
Feb 2024
Is CRISPR the New Sickle Cell Savior?
2023 ended with an exciting biotech breakthrough for sickle cell patients. A gene-editing therapy using the revolutionary CRISPR technology provides new hope and options for the nearly 100,000 Americans with sickle cell disease. In this episode, we talk with the company behind on ... Show More
24m 39s
Listen to millions of songs and podcasts on Anghami